Titan Biotech Limited (BOM:524717)
India
· Delayed Price · Currency is INR 422.85
-3.20 (-0.75%)
At close: Jun 17, 2025
Titan Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 215.32 | 248.53 | 248.44 | 216.84 | 303.35 | Upgrade
|
| Depreciation & Amortization | 41.7 | 33.04 | 25.74 | 23.47 | 22.08 | Upgrade
|
| Other Amortization | - | 0.27 | 0.27 | 0.22 | 0.12 | Upgrade
|
| Other Operating Activities | -20.32 | 2.4 | -33.07 | 13.18 | 34.27 | Upgrade
|
| Change in Accounts Receivable | -0.95 | 24.5 | -45.19 | 20.32 | -138.52 | Upgrade
|
| Change in Inventory | -51.52 | -94.02 | -14.9 | -78.52 | -45.62 | Upgrade
|
| Change in Accounts Payable | 18.48 | -21.82 | 13.89 | 24.88 | 15.13 | Upgrade
|
| Change in Other Net Operating Assets | -1.47 | 18.57 | 16.6 | - | - | Upgrade
|
| Operating Cash Flow | 201.23 | 211.46 | 211.78 | 220.41 | 190.82 | Upgrade
|
| Operating Cash Flow Growth | -4.84% | -0.15% | -3.91% | 15.50% | 211.98% | Upgrade
|
| Capital Expenditures | -93.69 | -194.85 | -127.34 | -63.11 | -30.11 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.16 | 2.21 | 2.94 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.47 | -0.37 | -0.07 | - | - | Upgrade
|
| Investment in Securities | -13.02 | -115.97 | -75.55 | -27.56 | - | Upgrade
|
| Other Investing Activities | 8.27 | 105.94 | -7.24 | -73.69 | -18.54 | Upgrade
|
| Investing Cash Flow | -98.75 | -203.04 | -207.25 | -164.37 | -48.65 | Upgrade
|
| Short-Term Debt Issued | - | 0.18 | 2.49 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 1.54 | 1.15 | - | 16.48 | Upgrade
|
| Total Debt Issued | - | 1.72 | 3.64 | - | 16.48 | Upgrade
|
| Short-Term Debt Repaid | -48 | - | - | -9.91 | - | Upgrade
|
| Long-Term Debt Repaid | -7.07 | -3.81 | -7.82 | -9.96 | -97.54 | Upgrade
|
| Total Debt Repaid | -55.06 | -3.81 | -7.82 | -19.87 | -97.54 | Upgrade
|
| Net Debt Issued (Repaid) | -55.06 | -2.09 | -4.18 | -19.87 | -81.05 | Upgrade
|
| Common Dividends Paid | -16.53 | -14.88 | -12.4 | -12.4 | -8.26 | Upgrade
|
| Other Financing Activities | -8.02 | -11.7 | -7.46 | -8.72 | -16.68 | Upgrade
|
| Financing Cash Flow | -79.61 | -28.66 | -24.03 | -40.99 | -105.99 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | Upgrade
|
| Net Cash Flow | 22.88 | -20.24 | -19.5 | 15.05 | 36.18 | Upgrade
|
| Free Cash Flow | 107.55 | 16.61 | 84.45 | 157.29 | 160.71 | Upgrade
|
| Free Cash Flow Growth | 547.32% | -80.33% | -46.31% | -2.13% | 162.76% | Upgrade
|
| Free Cash Flow Margin | 6.87% | 1.01% | 5.86% | 12.73% | 11.30% | Upgrade
|
| Free Cash Flow Per Share | 13.02 | 2.01 | 10.22 | 19.03 | 19.45 | Upgrade
|
| Cash Interest Paid | 8.02 | 7.96 | 4.5 | 5.99 | 14.2 | Upgrade
|
| Cash Income Tax Paid | 59.9 | 78.7 | 75 | 71.18 | 108.84 | Upgrade
|
| Levered Free Cash Flow | 67.81 | -46.26 | 28.91 | 107.87 | 163.34 | Upgrade
|
| Unlevered Free Cash Flow | 72.82 | -41.28 | 31.73 | 111.62 | 172.58 | Upgrade
|
| Change in Net Working Capital | 7.57 | 71.92 | 34.4 | 29.05 | 95.71 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.